GRAIL, Inc. Common Stock - Çeyreklik Mali Tablolar (NASDAQ:GRAL)

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Market Capitalization 2.1359 B
Employee 910
Founded 2015
CEO N/A
Website www.grail.com
Headquarter Delaware, United States
FIGI BBG01N6CGW43
Industry Tanı ve Araştırma

Toplam gelir

Net kar

Temel hisse başına kazanç (Temel EPS)

Toplam borç

Serbest nakit akışı

Nakit ve eşdeğerleri

2.14 B Piyasa değeri

Fiyat/kazanç oranı

-7.7

Fiyat/satışlar oranı

21.37

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.